Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

513 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

NCT05651932

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic San Francisco, California, United States
  • Mayo Clinic Hospital - Florida Jacksonville, Florida, United States
  • The Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

NCT06152575

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Western Regional Medical Center, Inc. dba. City of Hope Phoenix Goodyear, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Clovis Community Medical Center Clovis, California, United States
View all 270 locations
View Trial Details
Recruiting

Delayed Toxicities Post-CAR-T

NCT07665307

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations
  • UCSF Medical Center San Francisco, California, United States
  • Mount Sinai New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

NCT04879043

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Norton Healthcare, Inc. Louisville, Kentucky, United States
  • Nebraska Cancer Institute Omaha, Nebraska, United States
  • Mount Sinai, The Tisch Cancer Instutute New York, United States
View all 24 locations
View Trial Details
Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

NCT07649525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Frailty, +19 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Eastbourne District General Hospital Eastbourne, United Kingdom
  • St James University Hospital Leeds, United Kingdom
  • The Clatterbridge Cancer Centre - Liverpool Liverpool, United Kingdom
View Trial Details

Related conditions